Capricor Therapeutics (NASDAQ:CAPR) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Capricor Therapeutics will report an earnings per share (EPS) of $-0.36.
Investors in Capricor Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Historical Earnings Performance
During the last quarter, the company reported an EPS beat by $0.01, leading to a 8.99% increase in the share price on the subsequent day.
Here's a look at Capricor Therapeutics's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.36 | -0.11 | -0.09 | -0.29 |
| EPS Actual | -0.35 | -0.31 | -0.02 | -0.25 |
| Price Change % | 9.0% | -4.0% | 9.0% | 7.000000000000001% |
Performance of Capricor Therapeutics Shares
Shares of Capricor Therapeutics were trading at $19.54 as of November 11. Over the last 52-week period, shares are up 508.72%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for Capricor Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
